Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

The development marks a significant step in expanding high-quality, industry-relevant skilling frameworks across India.

All India Pharmacy Students Rights Forum (PSRF), All India Drug Control Officers’ Confederation (AIDCOC) and several other organisations and experts in the field of pharmacy have long been demanding ...

The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects due to a stubborn refusal to pay for innovative new medicines, according to the pharma ...

The pharma industry must transition towards innovation and complex generics over the next five years, including peptides, biosimilars, and biologics, to retain India's position as the pharmacy of the ...

NEW DELHI: The Centre has extended the deadline for applying for the ₹5,000-crore Promotion of Research and Innovation in Pharma & MedTech (PRIP) Scheme, planned to facilitate wider participation and ...

Tokyo, Japan and Cambridge, UK, 4 November 2025 – Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces that it will hold an R&D Day on 18 ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Three of the top four AI companies by market capitalization ...

In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...

In an effort to drive innovation in domestic pharma sector, the government is seeking applications for a scheme with an outlay of Rs 5,000 crore (around $600 million) over next five years, to shift ...

European pharmaceutical stocks traded sharply higher after President Trump unveiled plans to launch a drug-buying website for consumers and a pricing deal with Pfizer, in a move that analysts say ...

The Hindu hosted a webinar titled, ‘ Is the new draft B.Pharm syllabus making graduates market-ready?’, to look at what value additions have happened in the syllabus and how it is being implemented.